Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of Baseline Sleep Disturbances on Pimavanserin Response in Parkinson’s Disease Psychosis: A Post Hoc Analysis

Author:Chrones, Lambros   Naujoks, Karla   Zhang, Peter   Feng, Xiaoshu   Brunson, Greg   Krystal, Andrew   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Synucleinopathies  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.007  

Author Institution:Acadia Pharmaceuticals, Inc., Westmont, IL  Acadia Pharmaceuticals, Inc., San Diego, CA  Acadia Pharmaceuticals, Inc., North Potomac, MD  Acadia Pharmaceuticals, Inc., San Clemente, CA  Departments of Psychiatry and Neurology, University of California - San Francisco, San Francisco, CA  

Impact of Celebrity Stroke Disclosures: Online Trends and Public Awareness

Author:Patel, Radhika   Manu, Juliet   Karp, Adam   

Session Name:P11: Cerebrovascular Disease and Interventional Neurology: Epidemiology and Community Stroke Care  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P11.016  

Author Institution:New York Medical College, Valhalla, NY  New York Medical College, New York, NY  New York Medical College, Fair Lawn, NJ  

Impact of Community Education Levels on Cognitive Outcomes Post-COVID-19

Author:Blot, Cebastian   Brody, Pierce   Hammam, Salma   Vasilchenko, Daria   Alvarez, Zariya   Frontera, Jennifer   

Session Name:P1: Building Research Aspirations in Neurology (BRAIN)  

Topic:Global Health and Neuroepidemiology  

Program Number:P1.011  

Author Institution:NYU Langone Health, Moseley, VA  NYU Langone Health, New York, NY  NYU Langone Health, NY  NYU Langone Health, Staten Island, NY  NYU Langone Health, Brooklyn, NY  

Impact of Disease-modifying Treatments on Long-term Changes in the Choroid Plexus in Subjects With Radiologically Isolated Syndrome

Author:LANDES-CHATEAU, Cassandre   Stankoff, Bruno   Ricigliano, Vito AG   Mondot, Lydiane   Cohen, Mikael   YAZDAN PANAH, ARYA   Kantarci, Orhun   Okuda, Darin   Lebrun Frenay, Christine   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.008  

Author Institution:Nice University Hospital, France  Hopital De La Pitie Salpetriere, Paris, France  Hôpital Paris-Saclay, Orsay, France  Nice University Hospital, Nice, France  Institut du Cerveau et de la Moelle, Paris, France  Mayo Clinic, Rochester, MN  UT Southwestern Medical Center, Dallas, TX  

Impact of Early Fremanezumab Initiation and Treatment Pauses on the Reduction of Monthly Migraine Days: Analyses from the PEARL Study

Author:Pavão Martins, Isabel   Mitsikostas, Dimos Dimitrios   Tassorelli, Cristina   Kokturk, Pinar   Zuppone, Stefania   Ortega, Mario   Bryson, Juline   Ramirez Campos, Verena   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.007  

Author Institution:Centro de Estudos Egas Moniz, Faculty of Medicine, University of Lisbon, Lisbon, Portugal, Portugal  Department of First Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece, Athens, Greece  Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy  IRCCS C. Mondino Foundation, Pavia, Italy, Italy  Teva Netherlands B.V., Haarlem, The Netherlands, Netherlands  Teva Pharmaceutical Industries Ltd, Parsippany, NJ, USA, Parsippany, NJ  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, West Chester, PA  Teva Branded Pharmaceutical Products R&D, Inc., West Chester, PA, USA, PA